UnitedHealth Group, US91324P1021

UnitedHealth Group stock slips after earnings and guidance

Published on 08/29/2026 at 07:19 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

UnitedHealth Group stock is trading with a $354.17 billion market cap after Q2 revenue of $112.03 billion and EPS of $6.38. The latest analyst view points to a $456.56 average target and fiscal 2026 guidance of $19.50 to $20.00 per share.

Bauhaus-Poster mit geometrischen Primärfarben, Schutzschild und stilisierten menschlichen Figuren
UnitedHealth Group US91324P1021 im Bauhaus-Stil mit geometrischen Formen Primärfarben und abstrakten Menschenfiguren, Illustration mit AI erstellt.

UnitedHealth Group stock is trading with a $354.17 billion market cap after the company reported second-quarter EPS of $6.38 on revenue of $112.03 billion, a result that topped the $4.94 estimate and extended a run of earnings beats into 2026.

The same update also kept fiscal 2026 EPS guidance at $19.50 to $20.00 per share, while the analyst consensus in the latest market snapshot sat at $456.56. UnitedHealth Group Incorporated (US91324P1021) also showed a 52-week range of $255.96 to $461.62 and a recent opening price of $394.57.

Earnings still set the tone

The quarter ended June 30, 2026 remains the key reference point for investors because it delivered $6.38 in EPS versus $4.94 expected, a difference of $1.44. Revenue of $112.03 billion also came in above the $110.81 billion consensus, and the quarter's net margin reached 3.14%.

That combination matters because the current-year analyst estimate of $19.81 per share sits close to management's own $19.50 to $20.00 range. In other words, the market is still weighing whether UnitedHealth's operating profile can hold up after a 29.80% EPS surprise in the second quarter.

Consensus and valuation

The latest quote snapshot showed UNH at $394.57 on August 27, 2026, with a 50-day moving average of $413.42 and a 200-day moving average of $359.88. That puts the shares below the shorter average and above the longer one, a setup that leaves the stock between near-term momentum and longer-term trend support.

Analyst estimates in the current snapshot also show revenue of $446.53 billion for 2026 and EPS of $19.81, with next-year EPS at $22.44. Those figures leave the stock tied to execution more than to any one-day headline.

What the business sells

UnitedHealthcare and Optum remain the core platforms inside UnitedHealth Group. UnitedHealthcare manages health benefits and provider relationships, while Optum covers health services and care delivery across commercial, government, and individual markets.

Price and setup

UnitedHealth Group stock closed the latest visible session at $395.05 and traded at $395.57 overnight, keeping the share price far above the 52-week low of $255.96 and below the 52-week high of $461.62. The dividend line in the current snapshot also points to $2.32 per share, with an ex-date of September 14, 2026.

Company details

Company: UnitedHealth Group Incorporated

ISIN: US91324P1021

Ticker: UNH

Exchange: NYSE

Price (as of August 27, 2026, 4:00 p.m. ET): $395.05 USD

Market cap: $354.17 billion (as of August 29, 2026)

Sector / Industry: Health Care / Managed Health Care

Index membership: S&P 500

Next earnings date: September 22, 2026

Disclaimer...

en | US91324P1021 | UNITEDHEALTH GROUP | boerse | 70018195 | bgmi